COVID-19 monoclonal antibodies reduce risk of hospitalization and death

Monoclonal antibodies, a COVID-19 treatment given early after coronavirus infection, cut the risk of hospitalization and death by 60 percent in those most likely to suffer complications of the disease, according to an analysis of UPMC patients who received the medication compared to similar patients who did not.

from Top Health News -- ScienceDaily https://ift.tt/3oy0NJx